Prospective bone ultrasound patterns during childhood acute lymphoblastic leukemia treatment

被引:14
|
作者
Mussa, Alessandro [1 ]
Bertorello, Nicoletta [2 ]
Porta, Francesco [1 ]
Galletto, Chiara [2 ]
Nicolosi, Mario Guido [3 ]
Manicone, Rosaria [2 ]
Corrias, Andrea [1 ]
Fagioli, Franca [2 ]
机构
[1] Univ Turin, Regina Margherita Children Hosp, Dept Pediat Endocrinol & Diabetol, Div Pediat Endocrinol, I-10126 Turin, Italy
[2] Univ Turin, Dept Pediat Oncohematol, I-10126 Turin, Italy
[3] St Anna Hosp, Dept Gynecol & Obstet, Turin, Italy
关键词
Pediatrics; Childhood leukemia; Bone complications; Quantitative ultrasound; Fractures; PHALANGEAL QUANTITATIVE ULTRASOUND; YOUNG-ADULT SURVIVORS; HUMAN FINGER PHALANGES; MINERAL DENSITY; FRACTURE RISK; CHILDREN; TURNOVER; PROPAGATION; GEOMETRY; GROWTH;
D O I
10.1016/j.bone.2009.12.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Bone impairment is a well-known complication in childhood acute lymphoblastic leukemia (ALL) survivors but less is known about bone dynamics during ALL therapy. We longitudinally assessed by Quantitative Ultrasound (QUS) skeletal modifications during this treatment. Materials and methods: Forty-four newly diagnosed ALL children underwent bone measurement by QUS parameters BTT (Bone Transmission Time) and AD-SoS (Amplitude-Dependent Speed of Sound), mainly reliant on bone density and cortical thickness, respectively. Measurements were performed at diagnosis, and 6, 12, and 24 months thereafter. The occurrence of skeletal complications such as fractures, vertebral collapse, osteonecrosis, and osteopenia was related to measurement outcome. Results: A rapid deterioration of bone properties measured by Bit and AD-SoS was evident in the first semester of therapy (p<0.001). Subsequently, the next measurements were characterized by progressive uncoupling of the two QUS parameters (p<0.001). These were both significantly reduced at the end of therapy (p<0.001). Twelve subjects with in-treatment skeletal complications displayed an almost two-fold decrease of both parameters (p<0.001). Bit decreasing more than 1 Standard Deviation (SD) over 6 months of therapy was able to predict skeletal complication occurrence (p<0.001). Conclusion: This report represents the largest longitudinal cohort systematically submitted to bone condition assessment from the beginning to the end of therapy for childhood ALL. Bone deterioration occurs early and persists throughout therapy, consistent with bone properties uncoupling. This pattern possibly reflects an initial impairment of both mineral density and cortical thickness with a subsequent recovery of this latter. QUS permits an early detection of bone deterioration and related skeletal complications in childhood ALL. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:1016 / 1020
页数:5
相关论文
共 50 条
  • [41] Changes in body mass index during treatment of childhood acute lymphoblastic leukemia with the Nordic ALL2008 protocol
    Egnell, Christina
    Narhinen, Hanna
    Merker, Andrea
    Jonsson, Olafur G.
    Lepik, Kristi
    Niinimaki, Riitta
    Schmiegelow, Kjeld
    Stabell, Niklas
    Klug Albertsen, Birgitte
    Vaitkeviciene, Goda
    Ranta, Susanna
    Harila-Saari, Arja
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (06) : 656 - 663
  • [42] Esophageal Strictures During Treatment for Acute Lymphoblastic Leukemia
    Kelly, Kevin
    Storey, Lorna
    Sullivan, Maureen O'
    Butler, Karina
    McDermott, Michael
    Corbally, Martin
    McMahon, Corrina
    Smith, Owen P.
    Marcaigh, Aengus O'
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (02) : 124 - 127
  • [43] Little Evidence of Low Bone Mass in Acute Lymphoblastic Leukemia Survivors
    Muszynska-Roslan, Katarzyna
    Panasiuk, Anna
    Latoch, Eryk
    Krawczuk-Rybak, Maryna
    Konstantynowicz, Jerzy
    JOURNAL OF CLINICAL DENSITOMETRY, 2012, 15 (01) : 108 - 115
  • [44] PROGNOSTIC SIGNIFICANCE OF RADIOLOGICAL AND SYMPTOMATIC BONE INVOLVEMENT IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    HANN, IM
    GUPTA, S
    PALMER, MK
    MORRISJONES, PH
    MEDICAL AND PEDIATRIC ONCOLOGY, 1979, 6 (01): : 51 - 55
  • [45] Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors
    Genevieve, Nadeau
    Mojgan, Yazdanpanah
    Nahid, Yazdanpanah
    Vincenzo, Forgetta
    Simon, Girard
    Daniel, Sinnett
    Maja, Krajinovic
    Nathalie, Alos
    Despoina, Manousaki
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (02) : 130 - 138
  • [46] Parental functioning during maintenance treatment for childhood acute lymphoblastic leukemia: Effects of treatment intensity and dexamethasone pulses
    Rensen, Niki
    Steur, Lindsay M. H.
    Grootenhuis, Martha A.
    van Eijkelenburg, Natasha K. A.
    van der Sluis, Inge M.
    Dors, Natasja
    van den Bos, Cor
    Tissing, Wim J. E.
    Kaspers, Gertjan J. L.
    van Litsenburg, Raphaele R. L.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (11)
  • [47] Coagulation profile during induction chemotherapy in childhood acute lymphoblastic leukemia
    Sehgal, Shivali
    Sharma, Sunita
    Chandra, Jagdish
    Nangia, Anita
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2017, 60 (01) : 50 - 56
  • [48] Childhood relapsed acute lymphoblastic leukemia: Biology and recent treatment progress
    Goto, Hiroaki
    PEDIATRICS INTERNATIONAL, 2015, 57 (06) : 1059 - 1066
  • [49] Childhood acute lymphoblastic leukemia: refusal and abandonment of treatment in the southeast of Iran
    Naderi, Majid
    Esmaeili Reykande, Samira
    Tabibian, Shadi
    Alizadeh, Shaban
    Dorgalaleh, Akbar
    Shamsizadeh, Morteza
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2016, 46 (03) : 706 - 711
  • [50] Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia
    Umerez, Maitane
    Garcia-Obregon, Susana
    Martin-Guerrero, Idoia
    Astigarraga, Itziar
    Gutierrez-Camino, Angela
    Garcia-Orad, Africa
    PHARMACOGENOMICS, 2018, 19 (04) : 361 - 373